Recurrent Mantle Cell Lymphoma Withdrawn Phase Trials for Cytarabine (DB00987)

Also known as: Mantle Cell Lymphoma Recurrent

IndicationStatusPhase
DBCOND0028615 (Recurrent Mantle Cell Lymphoma)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01769911Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaTreatment